Skip to Content

Omalizumab Pregnancy and Breastfeeding Warnings

Omalizumab is also known as: Xolair

Omalizumab Pregnancy Warnings

Omalizumab has been assigned to pregnancy category B by the FDA. Animal studies have failed to reveal evidence of maternal toxicity, embryotoxicity, or teratogenicity. There are no controlled data in human pregnancy. Omalizumab is only recommended for use during pregnancy when benefit outweighs risk.

See references

Omalizumab Breastfeeding Warnings

There are no data on the excretion of omalizumab into human milk. Studies with cynomolgus monkeys have demonstrated milk levels that were 1.5% of maternal blood levels. IgG is excreted into human milk and it is expected that omalizumab is also excreted. The effects in the nursing infant are unknown. The manufacturer recommends that caution be used when administering omalizumab to nursing women.

See references

References for pregnancy information

  1. "Product Information. Xolair (omalizumab)." Genentech, South San Francisco, CA.

References for breastfeeding information

  1. "Product Information. Xolair (omalizumab)." Genentech, South San Francisco, CA.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.